The Mark H. and Blanche M. Harrington Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2007
NCT00507819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

sildenafil (viagra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypoplastic Left Heart Syndrome (Phase 2)

Tricuspid Atresia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1